Theracap131tm

Sodium Iodide (131I) is a radioactive iodine therapy used for thyroid conditions. This oral treatment targets overactive thyroid tissue or thyroid cancer cells. Commonly prescribed for hyperthyroidism and post-surgical ablation. Suitable for patients requiring targeted radiation.

Sodium Iodide (131I) is primarily used to treat hyperthyroidism, a condition where the thyroid gland produces excessive hormones. It is also employed in the management of thyroid cancer following surgery to destroy remaining cancerous tissue. This therapy helps reduce thyroid hormone production or eliminate malignant cells. Patients often ask, what is Sodium Iodide (131I) used for in thyroid treatment.

After administration, Sodium Iodide (131I) is absorbed by thyroid cells, where it emits radiation to reduce tissue activity. Common effects include temporary thyroid hormone fluctuations as the gland responds to treatment. Some patients may experience mild nausea or fatigue shortly after dosing. These effects typically subside as the body adjusts.

Sodium Iodide (131I) requires careful handling due to its radioactive nature. Patients should avoid close contact with others, especially children and pregnant individuals, for several days post-treatment. Follow healthcare provider instructions for isolation and hygiene practices. Proper disposal of bodily fluids is essential to minimize exposure risks.

Certain medications may interfere with Sodium Iodide (131I) effectiveness, including thyroid hormone supplements and iodine-containing drugs. Patients should inform their provider about all current medications, including over-the-counter supplements. Avoid iodine-rich foods or contrast agents before treatment, as they can reduce uptake by thyroid tissue. Alcohol and tobacco use may also impact treatment outcomes.